 CANTEL MEDICAL CORP. NYSE: CMD Cantel or the Company today announced the pricing of its offering of 140 million aggregate principal amount of 3.25 convertible senior notes due 2025 the Notes in a private offering only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended the Securities Act. The Company also granted the initial purchasers of the Notes an option to purchase, for settlement within a period of 13 days from, and including, the date on which the notes are first issued, up to an additional 28.0 million aggregate principal amount of Notes in the private placement. The issuance and sale of the Notes is scheduled to settle on or about May 15, 2020, subject to customary closing conditions. 